Saturday, May 3, 2025
HomeTagsBiopharmaceutical therapeutics

biopharmaceutical therapeutics

PCI Pharma Services Completes Acquisition of Ajinomoto Althea as Part of $1 Billion Investment Strategy Strengthening U.S. Pharmaceutical Manufacturing

PCI Pharma Services, a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharmaceutical therapeutics, has completed its acquisition of Ajinomoto Althea,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics